Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis

• Recent cross-sectional, population-based echocardiographic studies show that about half of all patients with heart failure have preserved left ventricular systolic function (HF-PSF). Cohort studies of hospitalized patients show a smaller proportion of HF-PSF. Compared to those with reduced systolic function, patients with HF-PSF are more often female, older, less likely to have coronary artery disease, and more likely to have hypertension. Patients with HF-PSF are less symptomatic and receive different pharmacologic therapy than patients with reduced systolic function. Morbidity and mortality rates in patients with HF-PSF are high but not quite as high as in patients with reduced systolic function. Though much has recently been learned about the syndrome of HF-PSF, many questions remain to be answered, not least how it should be treated.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Nyckelord

Adult

Aged

Aged

80 and over

Cardiovascular Agents/therapeutic use

Comorbidity

Female

Heart Failure

Congestive/drug

therapy/economics/*epidemiology/*physiopathology

Hospitalization/economics

Humans

Hypertension/*epidemiology

Male

Middle Aged

Myocardial Ischemia/*epidemiology

Prognosis

Quality of Life

Ventricular Function

Left/*physiology

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)